ImportRefusal LogoImportRefusal

Pillar5 Pharma Inc.

⚠️ Moderate Risk

FEI: 3000241849 • Arnprior, Ontario • CANADA

FEI

FEI Number

3000241849

📍

Location

Arnprior, Ontario

🇨🇦

Country

CANADA
🏢

Address

365 Madawaska Blvd, , Arnprior, Ontario, Canada

Moderate Risk

FDA Import Risk Assessment

39.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
4
Unique Violations
3/8/2021
Latest Refusal
10/9/2001
Earliest Refusal

Score Breakdown

Violation Severity
75.0×40%
Refusal Volume
28.8×30%
Recency
3.0×20%
Frequency
2.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1791×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

Refusal History

DateProductViolationsDivision
3/8/2021
60CBK09PHENYLEPHRINE HCL (ADRENERGIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/10/2006
65VAB99SEDATIVE N.E.C.
16DIRECTIONS
Florida District Office (FLA-DO)
11/1/2004
62GCP99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
11/1/2004
56YCP99ANTIBIOTIC N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
10/9/2001
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Pillar5 Pharma Inc.'s FDA import refusal history?

Pillar5 Pharma Inc. (FEI: 3000241849) has 5 FDA import refusal record(s) in our database, spanning from 10/9/2001 to 3/8/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Pillar5 Pharma Inc.'s FEI number is 3000241849.

What types of violations has Pillar5 Pharma Inc. received?

Pillar5 Pharma Inc. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Pillar5 Pharma Inc. come from?

All FDA import refusal data for Pillar5 Pharma Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.